Physician profile
John Avallone
NPI 1205846102
$172.64
in general payments reported to CMS, 2019-2025
7 companies · $54.66 in 2025
The $54.66 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.02 · 2020: $19.07 · 2021: $18.30 · 2023: $42.59 · 2025: $54.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $97.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $97.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $42.59 | 2023 | Omidria, Rayone Emv, Rayone Aspheric |
| Horizon Therapeutics Plc | $37.37 | 2020-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $28.55 | 2025 | Tecnis Iol |
| Harrow Eye, LLC | $26.11 | 2025 | |
| Omeros Corporation | $19.19 | 2019 | |
| Eyepoint US, INC. | $18.00 | 2019 | |
| Travere Therapeutics, INC. | $0.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Avallone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.